Last update 16 May 2025

MG-S-2525

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
MG S 2525
Target
MAP3K19
Action
inhibitors
Mechanism
MAP3K19 inhibitors(SPS1/STE20-related protein kinase YSK4 inhibitors)
Therapeutic Areas
Respiratory DiseasesOther Diseases
Active Indication
BronchiectasisIdiopathic Pulmonary Fibrosis
Inactive Indication
Pulmonary Disease, Chronic Obstructive
Originator Organization
Metagone Biotech, Inc.
Active Organization
Metagone Biotech, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC23H28N6O3
InChIKeyAWTYZRBONKSIES-UHFFFAOYSA-N
CAS Registry1951436-31-9

Related

1
Clinical Trials associated with MG-S-2525
NCT03650075
/ CompletedPhase 1
A Phase I Study to Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its Pharmacokinetic Profile in Healthy Volunteers
100 Clinical Results associated with MG-S-2525
Login to view more data
100 Translational Medicine associated with MG-S-2525
Login to view more data
100 Patents (Medical) associated with MG-S-2525
Login to view more data
100 Deals associated with MG-S-2525
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
BronchiectasisPhase 2-
Metagone Biotech, Inc.
26 Jun 2023
Idiopathic Pulmonary FibrosisPhase 2-
Metagone Biotech, Inc.
26 Jun 2023
Pulmonary Disease, Chronic ObstructivePhase 1
Taiwan Province
Metagone Biotech, Inc.
26 Jan 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free